Oral Plenary Session 1

Oral Plenary Session 2 – Fellows Plenary
Published: (2026)

Oral Concurrent Session 7 – Diabetes
Published: (2025)

Oral Concurrent Session 5 – Hypertension
Published: (2025)

Oral Concurrent Session 2 Diabetes
Published: (2026)

Oral Concurrent Session 2 – Diabetes
Published: (2026)

Oral Concurrent Session 1 – Equity, Public Health, and Policy
Published: (2025)

Oral Concurrent Session 1 Medical and Surgical Complications of Pregnancy
Published: (2026)

ORAL PLENARY SESSION 2: (Fellows Plenary)
Published: (2025)

Oral Concurrent Session 3 – Ultrasound and Genetics
Published: (2025)

Oral Concurrent Session 5 – Clinical Obstetrics
Published: (2026)

Oral Concurrent Session 5 Clinical Obstetrics
Published: (2026)

Oral Concurrent Session 2 – Clinical Obstetrics and Quality
Published: (2025)

Oral Concurrent Session 4 – Basic and Translational Science
Published: (2025)

Oral Concurrent Session 8 – Fetus and Fetal Intervention
Published: (2025)

Oral Concurrent Session 3 Fetus and Fetal Intervention
Published: (2026)

Oral Concurrent Session 3 – Fetus and Fetal Intervention
Published: (2026)

Oral Concurrent Session 4 Equity, Public Health, and Public Policy
Published: (2026)

Oral Concurrent Session 4 – Equity, Public Health, and Public Policy
Published: (2026)

Poster Session 1
Published: (2025)

Poster Session 1
Published: (2026)

Poster Session 1 Abstracts 98–397
Published: (2026)

Poster Session 4
Published: (2026)

Poster Session 2
Published: (2026)

Poster Session 3 Abstracts 698–997
Published: (2026)

Poster Session 4 Abstracts 998–1297
Published: (2026)

Poster Session 2 Abstracts 398–697
Published: (2026)

2025 SMFM Oral Schedule
Published: (2025)

2026 Pregnancy Meeting™ Oral Abstracts
Published: (2026)

POSTER SESSION 1: Abstracts 105–384
Published: (2025)

Low‐Dose Prophylactic Oral Iron Supplementation (Ferrous Fumarate, Ferrous Bisglycinate, and Ferrous Sulphate) in Pregnancy Is Not Associated With Clinically Significant Gastrointestinal Complaints: Results From Two Randomized Studies
by: Nils Thorm Milman, et al.
Published: (2024)

Sociodemographic barriers to continuous glucose monitoring among pregnancies with type 1 diabetes
by: Frank B. Will Williams, et al.
Published: (2025)

In utero ventriculosubgaleal shunt placement in a fetal lamb model: Phase 1 technical insights
by: Shohra Qaderi, et al.
Published: (2026)

Soluble fms‐like tyrosine kinase‐1 and placental growth factor as predictors of adverse maternal events in women with a confirmed diagnosis of preeclampsia
by: Niclas Carlberg, et al.
Published: (2026)

Optimizing diabetes care in pregnancy: A systematic review of glycemic targets, treatment initiation, and glucose‐lowering pharmacological management for T1DM, T2DM, and GDM
by: Gemma Villanueva, et al.
Published: (2026)

An overview of upcoming changes in pregnancy and lactation labeling information
by: Juan F. MOSLEY II
Published: (2015)

Feasibility of implementing a standardized preeclampsia risk screening tool into the electronic medical record
by: Daniella Rogerson, et al.
Published: (2025)